Literature DB >> 12634637

Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States.

Sean F Altekruse1, James V Lacey, Louise A Brinton, Patti E Gravitt, Steven G Silverberg, Willard A Barnes, Mitchell D Greenberg, Olympia C Hadjimichael, Larry McGowan, Rodrigue Mortel, Peter E Schwartz, Allan Hildesheim.   

Abstract

OBJECTIVE: Although human papillomavirus causes essentially all cervical carcinoma, cofactors may differ by cancer histologic type. We examined human papillomavirus genotypes and sexual and reproductive risk factors for cervical adenocarcinoma and squamous cell carcinoma. STUDY
DESIGN: One hundred twenty-four women with adenocarcinoma, 139 women with squamous cell carcinoma, and 307 control subjects participated in this case-control study. Logistic regression analyses were performed to calculate odds ratios and CIs.
RESULTS: Human papillomavirus 18 was associated most strongly with adenocarcinoma (odds ratio, 105; 95% CI, 23-487). Human papillomavirus 16 was associated most strongly with squamous cell carcinoma (odds ratio, 30; 95% CI, 12-77). More than three lifetime sexual partners was a risk factor for adenocarcinoma (odds ratio, 2.1; 95% CI, 1.1-4.0) and squamous cell carcinoma (odds ratio, 3.0; 95% CI, 1.6-5.9). Even being pregnant was associated inversely with adenocarcinoma (odds ratio, 0.4; 95% CI, 0.2-0.8). Five or more pregnancies was associated with squamous cell carcinoma (odds ratio, 2.2; 95% CI, 0.9-5.4).
CONCLUSION: The relative importance of human papillomavirus genotypes 16 and 18 and the reproductive co-factor differences suggest distinct causes for cervical adenocarcinoma and squamous cell carcinoma.

Entities:  

Mesh:

Year:  2003        PMID: 12634637     DOI: 10.1067/mob.2003.132

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

1.  High-grade cervical lesions among women attending a reference clinic in Brazil: associated factors and comparison among screening methods.

Authors:  Neide T Boldrini; Luciana B Freitas; Amanda R Coutinho; Flavia Z Loureiro; Liliana C Spano; Angélica E Miranda
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

2.  Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.

Authors:  Clara Bodelon; Margaret M Madeleine; Lisa G Johnson; Qin Du; Mari Malkki; Effie W Petersdorf; Stephen M Schwartz
Journal:  Gynecol Oncol       Date:  2011-11-28       Impact factor: 5.482

3.  Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.

Authors:  Philip E Castle; Ruth Shaber; Brandon J LaMere; Walter Kinney; Barbara Fetterma; Nancy Poitras; Thomas Lorey; Mark Schiffman; Anne Dunne; Janae M Ostolaza; Sharod McKinney; Robert D Burk
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

Review 4.  Clinical significance of human papilloma virus infection in the cervical lesions.

Authors:  Shuang Li; Yu-Han Meng; Hu Ting; Jian Shen; Ding Ma
Journal:  Front Med China       Date:  2010-07-16

5.  Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil.

Authors:  Rodrigo Lopes da Silva; Zulmira da Silva Batista; Gerusinete Rodrigues Bastos; Ana Paula Almeida Cunha; Fábio Vidal Figueiredo; Lailson Oliveira de Castro; Liwerbeth Dos Anjos Pereira; Marcos Antonio Custódio Neto da Silva; Flávia Castello Branco Vidal; Maria Claudene Barros; Elmary da Costa Fraga; Luciane Maria Oliveira Brito; Maria do Carmo Lacerda Barbosa; Miguel Ângelo Martins Moreira; Maria do Desterro Soares Brandão Nascimento
Journal:  BMC Womens Health       Date:  2020-08-01       Impact factor: 2.809

6.  CD83 polymorphisms and cervical cancer risk.

Authors:  Kelly J Yu; Janet S Rader; Ingrid Borecki; Zhengyan Zhang; Allan Hildesheim
Journal:  Gynecol Oncol       Date:  2009-05-15       Impact factor: 5.482

7.  Human papillomavirus genotypes in high-grade cervical lesions in the United States.

Authors:  Susan Hariri; Elizabeth R Unger; Suzanne E Powell; Heidi M Bauer; Nancy M Bennett; Karen C Bloch; Linda M Niccolai; Sean Schafer; Martin Steinau; Lauri E Markowitz
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

8.  REV1 genetic variants associated with the risk of cervical carcinoma.

Authors:  Xiaohong He; Feng Ye; Jing Zhang; Qi Cheng; Jiajie Shen; Huaizeng Chen
Journal:  Eur J Epidemiol       Date:  2008-05-10       Impact factor: 8.082

9.  Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97.

Authors:  Zigui Chen; Rob DeSalle; Mark Schiffman; Rolando Herrero; Robert D Burk
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

Review 10.  Human papillomaviruses: genetic basis of carcinogenicity.

Authors:  Robert D Burk; Zigui Chen; Koenraad Van Doorslaer
Journal:  Public Health Genomics       Date:  2009-08-11       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.